Summary
Definición
Anamnesis y examen
Principales factores de diagnóstico
- hypertension
- tachycardia
- chest pain
- mydriasis
- diaphoresis
- tremulousness
- agitation (mild to severe)
- mood changes (e.g., irritability, euphoria, dysphoria, paranoia)
- suicide ideation
Otros factores de diagnóstico
- anxiety (panic state: mild to severe)
- drug-induced formication
- previous hospitalisation for medically supervised withdrawal
- heat-related injuries (e.g., blisters, sores, and cuts on the mouth) or burns on the thumbs
- nasal septum ulceration, perforation
- focal neurological abnormalities
- seizure activity
- loss of consciousness/altered consciousness
- skin lesions (e.g., puncture marks, infections, erosions, necrosis)
- dyspnoea
Factores de riesgo
- adverse childhood events
- history of polysubstance use
- family history of substance use disorders
- history of mental health disorder
- male sex
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- urine toxicology ± gas chromatography/mass spectrometry testing
- ECG
- cardiac enzymes
Pruebas diagnósticas que deben considerarse
- chest x-ray
- CT head
- electroencephalogram
- comprehensive blood panel
- hepatitis serology
- HIV serology
Algoritmo de tratamiento
acute intoxication
non-pregnant adults and adolescents: mild cocaine use disorder
non-pregnant adults and adolescents: moderate to severe cocaine use disorder
pregnant
sustained remission
treatment resistant
Colaboradores
Autores
Kim Wolff, MBE, PhD
Professor of Analytical, Forensic, and Addiction Science, Director, King’s Forensics
Faculty Life Science and Medicine
King’s College London
London
UK
Divulgaciones
KW declares that she has no competing interests.
Agradecimientos
Professor Kim Wolff would like to gratefully acknowledge Dr Steven B. Karch, the previous contributor to this topic.
Divulgaciones
SBK is an author of a number of references cited in this topic. SBK gives expert testimony and receives royalties from a textbook that he authored.
Revisores por pares
Andrew J. Saxon, MD
Professor
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle
WA
Divulgaciones
AS declares that he receives royalties from UpToDate, Inc.
Adam Bisaga, MD
Professor
Clinical Psychiatry
Columbia University College of Physicians and Surgeons
New York City
NY
Divulgaciones
AB declares that his research team and institution received funding and medication donations from Alkermes.
Christos Kouimtsidis, MBBS, MSc, MRCPsych, PhD
Consultant Psychiatrist and Honorary Senior Lecturer
Addictions, Alcohol Research
Institute of Psychiatry
King's College London
London
UK
Divulgaciones
CK declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
Clinical Guideline Committee (CGC) Members, ASAM Team, AAAP Team, et al. The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. J Addict Med. 2024 May-Jun 01;18(1s suppl 1):1-56.Texto completo Resumen
Department of Health and Social Care. Drug misuse and dependence: UK guidelines on clinical management. Dec 2017 [internet publication].Texto completo
World Health Organization. Guidelines for identification and management of substance use and substance use disorders in pregnancy. Nov 2014 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Thyrotoxicosis
- Amfetamine and methamphetamine use disorder
- Mood disorder
Más DiferencialesGuías de práctica clínica
- Engagement and retention of nonabstinent patients in substance use treatment
- The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder
Más Guías de práctica clínicaFolletos para el paciente
Cocaine use disorder
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad